Your browser doesn't support javascript.
loading
Surgery for obstructive hypertrophic cardiomyopathy: challenge and future / 中华外科杂志
Chinese Journal of Surgery ; (12): 181-186, 2023.
Article in Chinese | WPRIM | ID: wpr-970178
ABSTRACT
After more than 60 years of development, with the deepening of the pathophysiological understanding of obstructive hypertrophic cardiomyopathy, the extent and resection thickness of myectomy have increased significantly. Myectomy combined with the correction of anomalies of the mitral valve apparatus has become the standard treatment of obstructive hypertrophic cardiomyopathy. Only a few centers worldwide can routinely perform it due to the difficulty. Because of the advances of new drugs and interventional therapy, the development of surgical treatment faces many challenges. At the same time, generations of cardiovascular surgeons are constantly trying to promote septal myectomy, including developing devices and the surgical field, as well as improving surgical planning by advanced technology. At present, the superior long-term efficacy of septal myectomy has been confirmed. It is necessary to work together to promote the treatment of hypertrophic obstructive cardiomyopathy, so as to guard people's health.
Subject(s)
Full text: Available Index: WPRIM (Western Pacific) Main subject: Cardiomyopathy, Hypertrophic / Treatment Outcome / Heart Septum / Mitral Valve / Mitral Valve Insufficiency Limits: Humans Language: Chinese Journal: Chinese Journal of Surgery Year: 2023 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Cardiomyopathy, Hypertrophic / Treatment Outcome / Heart Septum / Mitral Valve / Mitral Valve Insufficiency Limits: Humans Language: Chinese Journal: Chinese Journal of Surgery Year: 2023 Type: Article